Cited by 244Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of -Amyloid

Open access

Abstract

Alzheimer's disease (AD) is the major cause of dementia. During the development of AD, neurofibrillary tangles progress in a fixed pattern, starting in the transentorhinal cortex followed by the hippocampus and cortical areas. In contrast, the deposition of β-amyloid (Aβ) plaques, which are the other histological hallmark of AD, does not follow the same strict spatiotemporal pattern, and it correlates poorly with cognitive decline. Instead, soluble Aβ oligomers have received increasing attention as probable inducers of pathogenesis. In this study, we use microinjections into electrophysiologically defined primary hippocampal rat neurons to demonstrate the direct neuron-to-neuron transfer of soluble oligomeric Aβ. Additional studies conducted in a human donor-acceptor cell model show that this Aβ transfer depends on direct cellular connections. As the transferred oligomers accumulate, acceptor cells gradually show beading of tubulin, a sign of neurite damage, and gradual endosomal leakage, a sign of cytotoxicity. These observations support that intracellular Aβ oligomers play a role in neurodegeneration, and they explain the manner in which Aβ can drive disease progression, even if the extracellular plaque load is poorly correlated with the degree of cognitive decline. Understanding this phenomenon sheds light on the pathophysiological mechanism of AD progression. Additional elucidation will help uncover the detailed mechanisms responsible for the manner in which AD progresses via anatomical connections and will facilitate the development of new strategies for stopping the progression of this incapacitating disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.0615-12.2012

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 50 references

Cited by

Sorted by citations

Items 201–244 of 244

Metadata

Authors
Nath, S., Agholme, L., Kurudenkandy, F. R., Granseth, B., Marcusson, J., & Hallbeck, M.
Affiliations
Linköping University (SE)
Venue
Journal of Neuroscience
Published
2012-06-27
Volume
32
Issue
26
Pages
8767-8777
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2100421640
Cited by
244
References
50
Citations by year
2026: 10 · 2025: 10 · 2024: 14 · 2023: 11 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 19 · 2017: 17 · 2016: 28 · 2015: 13 · 2014: 25 · 2013: 27 · 2012: 5
FWCI
15.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fondation pour la Recherche Médicale
  • Vetenskapsrådet
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, amyloid-beta oligomers, neurodegeneration, hippocampal neurons, amyloid plaques, disease progression, cognitive decline
MeSH terms
Animals, Animals, Newborn, Cell Communication, Cell Differentiation, Cells, Cultured, Dendrites, Dose-Response Relationship, Drug, Endocytosis, Exocytosis, Female, Heterocyclic Compounds, 3-Ring, Hippocampus, Humans, Male, Membrane Glycoproteins, Microinjections, Nerve Degeneration, Nerve Tissue Proteins, Synaptic Transmission, Neuroblastoma, Neuroglia, Neurons, Peptide Fragments, Rhodamines, Tetrazolium Salts, Thiazoles, Time Factors, Transfection, Amyloid beta-Peptides, Rats, Sprague-Dawley, Patch-Clamp Techniques, Coculture Techniques, Neocortex, rab5 GTP-Binding Proteins, Microscopy, Electron, Transmission, Green Fluorescent Proteins, Rats, Lysosomal-Associated Membrane Protein 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review